ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,163Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 807

$628K Total Retail Price of All Prescriptions

Rank: 58 out of 807

589 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 589 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

0% of this provider’s 10,435 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
FUROSEMIDE 568 508 1 6
SIMVASTATIN 553 482 2 1
METOPROLOL TARTRATE 485 440 3 8
WARFARIN SODIUM 427 378 4 10
OMEPRAZOLE 365 321 5 4
LISINOPRIL 315 272 6 2
LEVOTHYROXINE SODIUM 291 275 7 3
POTASSIUM CHLORIDE 290 262 8 18
AMLODIPINE BESYLATE 246 216 9 5
TRAMADOL HCL 237 192 10 19
HYDROCODONE-ACETAMINOPHEN 219 143 S3 11 15
METFORMIN HCL 189 167 12 12
SERTRALINE HCL 184 168 13 22
ATENOLOL 176 167 14 7
LOSARTAN POTASSIUM 174 151 15 14
GABAPENTIN 173 123 16 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 146 133 17 28
ALLOPURINOL 139 127 18 26
CITALOPRAM HBR 137 124 19 17
CIPROFLOXACIN HCL 126 100 20 72
DONEPEZIL HCL 123 123 21 31
NAMENDA 121 121 22 54
RANITIDINE HCL 118 111 23 34
DIGOXIN 117 109 24 41
PROAIR HFA 115 79 25 43
METOPROLOL SUCCINATE 101 87 26 13
TAMSULOSIN HCL 99 96 27 27
HYDROCHLOROTHIAZIDE 97 79 28 9
GLIMEPIRIDE 91 83 29 51
FAMOTIDINE 89 73 30 90
ISOSORBIDE MONONITRATE ER 88 78 31 36
ALENDRONATE SODIUM 86 82 32 20
PANTOPRAZOLE SODIUM 81 67 33 44
SYMBICORT 79 66 34 116
CRESTOR 77 66 35 32
ZOLPIDEM TARTRATE 76 55 36 23
ADVAIR DISKUS 76 55 36 33
LANTUS SOLOSTAR 75 53 38 42
PREDNISONE 74 67 39 24
PRAVASTATIN SODIUM 73 68 40 21
BYSTOLIC 70 67 41 150
CEPHALEXIN 68 59 42 135
KLOR-CON M20 66 66 43 83
TRIAMTERENE-HCTZ 65 59 44 29
TRAZODONE HCL 64 38 45 25
MIRTAZAPINE 63 56 46 38
SPIRIVA 61 46 47 50
CARVEDILOL 60 55 48 35
FLUTICASONE PROPIONATE 59 50 49 30
QUETIAPINE FUMARATE 59 59 49 66
FENTANYL 57 47 S2 51 65
POLYETHYLENE GLYCOL 3350 57 56 51 40
ATORVASTATIN CALCIUM 56 48 53 11
NEXIUM 53 24 54 68
GEMFIBROZIL 52 49 55 74
ISOSORBIDE DINITRATE 51 50 56 222
AZITHROMYCIN 50 46 57 57
NYSTATIN 50 31 57 148
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.